Chemkart India IPO is a bookbuilding of ₹80.08 crores. The issue is a combination of fresh issue of 26.00 lakh shares aggregating to ₹64.48 crores and offer for sale of 6.29 lakh shares aggregating to ₹15.60 crores.
Chemkart India IPO bidding opened for subscription on July 7, 2025 and will close on July 9, 2025. The allotment for the Chemkart India IPO is expected to be finalized on Thursday, July 10, 2025. Chemkart India IPO will be list on BSE SME with a tentative listing date fixed as Monday, July 14, 2025.
Chemkart India IPO price band is set at ₹236 to ₹248 per share. The lot size for an application is 600. The minimum amount of investment required by an individual investor (retail) is ₹2,83,200 (1,200 shares). The minimum lot size investment for HNI is 3 lots (1,800 shares) amounting to ₹4,46,400.
Incorporated in 2015, Chemkart India Limited is a B2B distributor specializing in high-quality food and health ingredients. The company serves as a vital link between global ingredient manufacturers and businesses involved in the production of health supplements, including sports nutrition, vitamins, and protein-based products. With a strong focus on variety, affordability, quality, and customer relationships, Chemkart enhances supply chain efficiency for its clients.
The company offers value-added services such as grinding, blending, and packaging at its hygienic processing facility located in Bhiwandi, Mumbai. Spanning 28,259.16 sq. ft., the facility is well-equipped for efficient handling, labeling, and sealing of ingredients.
Chemkart’s product portfolio includes a wide range of essential health and nutrition components such as Amino Acids (vital for metabolism and biological functions), Health Supplements (for general wellbeing), Herbal Extracts (used for therapeutic and functional purposes), Nucleotides (supporting immune and gut health), Proteins (crucial for muscle and immune function), Sports Nutrition ingredients (for endurance and recovery), and Vitamins (key micronutrients for physiological functions).
IPO stands for "Initial Public Offering." It's the process through which a privately-held company becomes publicly traded by offering its shares to the general public and listing them on a stock exchange for trading. This allows the company to raise capital from investors and grants individuals and institutions the opportunity to invest in and own a portion of the company.
The life cycle of an IPO, or Initial Public Offering, begins with a company's decision to go public. It involves hiring underwriters, registering with regulatory authorities, determining the IPO price, marketing to investors, and the subscription period where investors place orders for shares. After allocation and listing, shares become publicly tradable, and the company enters the secondary market. Ongoing reporting and corporate governance are crucial as the company continues to operate as a publicly-traded entity. The IPO aims to raise capital for growth and provides investors with opportunities to trade shares in the company.
An IPO (Initial Public Offering) is when a private company goes public by selling shares to the public. Investors buy these shares, giving them ownership in the company. It's a way for companies to raise capital and expand. The process involves underwriters, regulatory filings, setting the IPO price, and marketing to investors. After the IPO, shares can be traded on a stock exchange. IPOs offer opportunities and risks, so investors should research and consider carefully.
"Upcoming IPOs" refers to initial public offerings that have been announced by private companies but have not yet occurred. These are companies that plan to go public in the near future by issuing shares to the public and listing them on a stock exchange. Investors often keep an eye on upcoming IPOs as they represent opportunities to invest in companies at their early stages of public trading, potentially capturing growth potential. These offerings are typically accompanied by significant media and investor attention as they approach their launch dates.